1Arampatzis C,Goedhart D,Serruys P,et al.On behalf of the LIPS investigators.Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention-A Lescol Intervention Prevention Study (LIPS) substudy.Am H J,2005,149(2):329.
2Pasceri V,Patti G,Nusca A,et al.The ARMYDA Investigators randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention:Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study.Circulation,2004,110(6):674.
3Petronio A,Amoroso G,Limbruno U,et al.Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coron-ary stenting:A randomized study with intravascular ultrasound.Am H J,2005,149(3):520.
4The post coronary Artery By pass Graft Trial Ingestigation.The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenousvein coronary artery bypass grafts.N Eng J Med,1997,336(3):153.
5Mary E,Charlson O,Wayne Ison.Care after coronary-artery bypass surgery.N Eng Med,2003,348(15):1456.
6Pan W,Pintar T,Anton J,et al.Statins are associated with a reduced incidence of periopera -tive mortality after coronary artery bypass graft surgery.Circulation,2004,110(11):45.
7Collins R,Armitage J,Parishi S,et al.MRC/BHF Heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes:a randomized placebo-controlled trial.Lancet,2003,361(9374):2005.
8SommeiJ,MacGillavry M,Meijers J,et al.Anti-Inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes.Diabetes care,2004,27(2):468.
9Wenket K,Meiser B,Thiery J,et al.Simvastatin initiated early after heart transplantation:8-year prospective experience.Circulation,2003,107(1):93.
10Sever PS,Dahlof B,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):a multicentre randomized controlled trial.Lancet,2003,361:1149.
